InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,652.00
(
0.06%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,819.06
(
0.04%
)
Post# of 3687
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

jefra1965

Send PM Follow Ignore
Followers 17
Posts 2328
Boards Moderated 0
Alias Born 10/26/2017

jefra1965

Re: None

Saturday, 02/13/2021 5:43:17 PM

Saturday, February 13, 2021 5:43:17 PM

Post# of 3687
$CVLB
I have ran my numbers several times and I am estimating between $18 and $18.5m ($18.25 Midpoint) for Q1'21 which puts it in line with a $90.00-$105.00M for the year. This is only the current brands without the revenue contribution of the new ones NavaMD & LifeMD.

Reasons for the the step increase are the following:
1. The straight Q1 sequential increase of around $2.8-3M
2. $1.01M from the additional 22% of LSS revenue which started on Jan22. Numbers ran by percentages of days.
3. An increase in the call center seats by the end of the quarter.
4. Shapiro business model got improved into a subscription model.
5. Conversion efficiencies by VeritasMD and some savings.
6. New products in the RexMD brand and cross selling.
7. Ramp up in the sales & marketing spend with new cash.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up